CN106072182A - A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet - Google Patents
A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet Download PDFInfo
- Publication number
- CN106072182A CN106072182A CN201610431766.4A CN201610431766A CN106072182A CN 106072182 A CN106072182 A CN 106072182A CN 201610431766 A CN201610431766 A CN 201610431766A CN 106072182 A CN106072182 A CN 106072182A
- Authority
- CN
- China
- Prior art keywords
- potato
- powder
- radix
- rhizoma
- fagopyri tatarici
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000061456 Solanum tuberosum Species 0.000 title claims abstract description 154
- 235000002595 Solanum tuberosum Nutrition 0.000 title claims abstract description 154
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 38
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000002156 mixing Methods 0.000 title claims description 15
- 235000013399 edible fruits Nutrition 0.000 title claims 11
- 239000000843 powder Substances 0.000 claims abstract description 88
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 68
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 68
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 68
- 235000005493 rutin Nutrition 0.000 claims abstract description 68
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 68
- 229960004555 rutoside Drugs 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 239000004365 Protease Substances 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims abstract description 13
- 108091005804 Peptidases Proteins 0.000 claims abstract description 12
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract 8
- 229920001592 potato starch Polymers 0.000 claims description 41
- 238000000605 extraction Methods 0.000 claims description 26
- 239000012670 alkaline solution Substances 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 12
- 235000019419 proteases Nutrition 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 239000004567 concrete Substances 0.000 claims description 4
- 102000005600 Cathepsins Human genes 0.000 claims description 3
- 108010084457 Cathepsins Proteins 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 230000001007 puffing effect Effects 0.000 claims description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 3
- 235000011152 sodium sulphate Nutrition 0.000 claims description 3
- 235000010265 sodium sulphite Nutrition 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000000643 oven drying Methods 0.000 claims 2
- 238000007789 sealing Methods 0.000 claims 2
- 244000063299 Bacillus subtilis Species 0.000 claims 1
- 235000014469 Bacillus subtilis Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000003760 hair shine Effects 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 244000130270 Fagopyrum tataricum Species 0.000 abstract description 161
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract description 161
- 235000013305 food Nutrition 0.000 abstract description 19
- 235000016709 nutrition Nutrition 0.000 abstract description 18
- 239000000047 product Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 62
- 235000012015 potatoes Nutrition 0.000 description 44
- 240000008620 Fagopyrum esculentum Species 0.000 description 27
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 238000002386 leaching Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 229920002472 Starch Polymers 0.000 description 13
- 239000002002 slurry Substances 0.000 description 13
- 239000008107 starch Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 235000019698 starch Nutrition 0.000 description 12
- 229940093797 bioflavonoids Drugs 0.000 description 11
- 240000007594 Oryza sativa Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 108010059820 Polygalacturonase Proteins 0.000 description 10
- 108010093305 exopolygalacturonase Proteins 0.000 description 10
- 235000013312 flour Nutrition 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 239000003925 fat Substances 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 238000002791 soaking Methods 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 244000070406 Malus silvestris Species 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000021016 apples Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000005360 mashing Methods 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 235000007708 morin Nutrition 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 235000013573 potato product Nutrition 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229960003232 troxerutin Drugs 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- HGEFWFBFQKWVMY-RQOWECAXSA-N (z)-3-(2,4-dihydroxyphenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C/C1=CC=C(O)C=C1O HGEFWFBFQKWVMY-RQOWECAXSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- CFXJOMGPUADAJE-UHFFFAOYSA-N 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptan-5-ol Chemical compound C1C(O)C2C(=C)C(C)(C)C1C2 CFXJOMGPUADAJE-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000000386 Hypertensive Intracranial Hemorrhage Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000011128 cardiac conduction Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种能够制得营养价值较高的口含片的苦荞马铃薯汁液干燥物混合口含片的制备方法。该方法先将苦荞粉与清水按照一定比例混合得到苦荞液体,然后在苦荞液体中加入复合蛋白酶进行酶解处理;接着将经过酶解处理的苦荞液体静置后取上清液,并将上清液进行喷雾干燥处理或真空浓缩处理得到苦荞粉状物,再将马铃薯汁进行喷雾干燥处理或真空浓缩处理得到马铃薯粉状物;最后将得到的苦荞粉状物、马铃薯粉状物与芦丁粉、马铃薯粉按照一定比例混合得到基料,并将基料按照常规口含片的制作工艺制成口含片,利用该方法可以制得一种高含量苦荞、芦丁和马铃薯的口含片,其营养价值较高。适合在食品领域推广应用。The invention discloses a preparation method of a tartary buckwheat potato juice dried product mixed buccal tablet capable of preparing buccal tablets with high nutritional value. In this method, tartary buckwheat powder and clear water are mixed according to a certain ratio to obtain tartary buckwheat liquid, and then compound protease is added to the tartary buckwheat liquid for enzymolysis treatment; then the enzymolysis-treated tartary buckwheat liquid is left to stand and the supernatant is taken, And the supernatant is spray-dried or vacuum-concentrated to obtain tartary buckwheat powder, and then the potato juice is spray-dried or vacuum-concentrated to obtain potato powder; finally, the obtained tartary buckwheat powder, potato powder The base material is mixed with rutin powder and potato powder according to a certain ratio, and the base material is made into buccal tablets according to the conventional buccal tablet manufacturing process, and a kind of high-content tartary buckwheat and rutin can be prepared by using this method. and potato buccal tablets, which have high nutritional value. It is suitable for promotion and application in the food field.
Description
技术领域technical field
本发明涉及食品领域,具体涉及一种苦荞马铃薯汁液干燥物混合口含片的制备方法。The invention relates to the field of food, in particular to a preparation method of tartary buckwheat potato juice dried product mixed buccal tablet.
背景技术Background technique
苦荞是自然界中甚少的药食两用作物,据《本草纲目》记载:苦荞味苦,性平寒,能实肠胃,益气力,续精神,利耳目,炼五脏渣秽;在《千金要方》、《中药大辞典》及相关文献中对苦荞都有记载:可安神、活气血、降气宽肠、清热肿风痛、祛积化滞、清肠、润肠、通便、止咳、平喘、抗炎、抗过敏、强心、减肥、美容等功效。苦荞即苦荞麦,学名鞑靼荞麦(鞑靼,读音dádá,是对中国古代北方少数民族的统称),别名荞叶七、野兰荞、万年荞、菠麦、乌麦、花荞。比甜荞即荞麦的营养价值高出很多。特别是生物类黄酮的含量是荞麦的13.5倍。苦荞--七大营养素完全集于一身,不是药,不是保健品,是能当饭吃的食品,却有着卓越的营养保健价值和非凡的食疗功效。它不属禾本科,而属蓼科,与人们所熟悉的“何首乌、大黄”等同属蓼科,是我国药食同源文化的典型体现。苦荞被誉为“五谷之王”,三降食品(降血压,降血糖,降血脂)。苦荞拥有独特、全面、丰富的营养成份,而且药用特性好,有人体所必须的多种营养成份。苦荞有通便排毒的功效,民间又称其为“净肠草”。苦荞还可以炒制后做成茶饮,每日饮用对三高患者有辅助治疗作用。Tartary buckwheat is a rare medicinal and edible crop in nature. According to the "Compendium of Materia Medica": Tartary buckwheat is bitter in taste and cold in nature. Tartary buckwheat has been recorded in "Thousand Gold Prescriptions", "Dictionary of Traditional Chinese Medicine" and related documents: it can soothe the nerves, activate qi and blood, lower qi and widen the intestines, clear away heat, swelling and pain, dispel accumulation and stagnation, cleanse the intestines, moisten the intestines, and clear the intestines. Convenience, cough, asthma, anti-inflammatory, anti-allergic, cardiotonic, weight loss, beauty and other effects. Tartary buckwheat is tartary buckwheat, the scientific name is Tartary buckwheat (Tatar, pronounced dádá, is a collective name for the ancient northern minorities in China), and it is also known as buckwheat seven, wild blue buckwheat, Wannian buckwheat, spinwheat, black wheat, flower buckwheat. The nutritional value of buckwheat is much higher than that of sweet buckwheat. In particular, the content of bioflavonoids is 13.5 times that of buckwheat. Tartary buckwheat -- the seven major nutrients are completely integrated into one body. It is not a medicine, not a health product, but a food that can be eaten as a meal, but it has excellent nutritional and health care values and extraordinary therapeutic effects. It does not belong to Poaceae, but belongs to Polygonaceae, which belongs to Polygonaceae with familiar "polygonum multiflorum and rhubarb". It is a typical embodiment of the culture of homology of medicine and food in my country. Tartary buckwheat is known as the "King of the Five Grains", and it is a food that can lower blood pressure, lower blood sugar, and lower blood fat. Tartary buckwheat has unique, comprehensive and rich nutritional components, and has good medicinal properties, and has various nutritional components necessary for the human body. Tartary buckwheat has the effect of laxative and detoxification, and it is also called "cleaning grass" among the people. Tartary buckwheat can also be roasted and made into tea, drinking it every day has an auxiliary therapeutic effect on patients with three highs.
苦荞起源于我国西南部,人们出于粮用目的习惯地把它归于禾谷类、麦类,归小宗粮豆作物,实际上苦荞是食药兼用的食物源。中国科学家研究发现:苦荞是五谷杂粮中的奇葩,有很高食用价值和医疗保健作用,是一种极具开发潜力的功能性食品原料。食用苦荞直观显示效果是利尿通便。检测数据显示,苦荞具有降血糖、降血脂、降尿糖、疗胃疾和改善便秘的“三降一疗两通”的食疗营养功能。Tartary buckwheat originated in the southwestern part of my country. People habitually classify it as cereals and wheat for food purposes, and as small grain and bean crops. In fact, tartary buckwheat is a food source for both food and medicine. Chinese scientists have found that tartary buckwheat is a wonderful flower among the whole grains, has high edible value and health care function, and is a functional food raw material with great development potential. The intuitive display effect of eating tartary buckwheat is diuretic and laxative. The test data shows that tartary buckwheat has the dietary and nutritional functions of "three reductions, one treatment and two treatments" of lowering blood sugar, lowering blood fat, lowering urine sugar, treating stomach diseases and improving constipation.
市场上很多销售的苦荞多做成苦荞茶,不过大多苦荞茶经过膨化处理,或者是粉碎后再加工,虽然卖相较好,但是会破坏苦荞的有效成分。另外,生的苦荞需要经过适当的烘培加工后才可做茶饮用,但是苦荞的烘培工艺要求较高,很容易炒过炒糊,或者炒的火候不到,破坏苦荞的有效成份,影响口感以及芦丁的渗出率。苦荞的蛋白质、脂肪都高于小麦面粉和大米,蛋白质高于玉米面粉。维生素B2高于小麦面粉、大米,是玉米面粉的4~24倍。矿质营养元素也都不同程度高于其他粮种。苦荞还含有米、面及其他谷物没有的营养活性因子:苦荞黄酮:含芦丁、槲皮素、双色素、莰菲醇等酚类物质,有软化血管,改善微循环,清热解毒、活血化瘀、降血糖、尿糖、血脂,加强胰岛素外周作用。Many tartary buckwheat sold in the market are mostly made into tartary buckwheat tea, but most tartary buckwheat teas are processed after puffing or crushing. Although they look good, they will destroy the active ingredients of tartary buckwheat. In addition, raw tartary buckwheat needs to be roasted and processed properly before it can be used as tea. However, the baking process of tartary buckwheat is relatively high, and it is easy to over-fry or fry it under low heat, which will destroy the effectiveness of tartary buckwheat. The ingredients affect the taste and the exudation rate of rutin. Tartary buckwheat has higher protein and fat than wheat flour and rice, and higher protein than corn flour. Vitamin B2 is higher than that of wheat flour and rice, and 4 to 24 times that of corn flour. Mineral nutrients are also higher than other grains to varying degrees. Tartary buckwheat also contains nutritionally active factors that rice, flour and other grains do not have: Tartary buckwheat flavonoids: contain phenolic substances such as rutin, quercetin, bipigment, and camphenyl alcohol, which can soften blood vessels, improve microcirculation, clear away heat and detoxify, Promote blood circulation and remove blood stasis, lower blood sugar, urine sugar, blood lipids, and strengthen the peripheral action of insulin.
苦荞糖醇可在人体肠道微生物的作用下降解D—手性肌醇,提高胰岛素的敏感性,从而降低动物和人体的血糖、血脂水平。2,4—二羟基顺式肉桂酸:含有抑制皮肤生成黑色素物质,可预防老年斑和雀斑。蛋白质阻碍酶:有阻碍白血病细胞的增殖作用。抗(慢)消化淀粉有阻止血糖快升和减肥的作用。对850名彝民调查表明,每天食用100克苦荞麦面粉可降低胆固醇和低密度脂蛋白。62名汉人Ⅱ型糖尿病患者每天冲喝6克苦荞降糖茶,18个月后降低空腹和餐后血糖效果明显,显效和有效合计占90.32%。便秘患者和普通人食用苦荞茶7-10天,轻松如厕。Buckwheat alcohol can degrade D-chiro-inositol under the action of human intestinal microorganisms, improve insulin sensitivity, thereby reducing blood sugar and blood lipid levels in animals and humans. 2,4-Dihydroxycis-cinnamic acid: Contains substances that inhibit the skin from producing melanin, and can prevent age spots and freckles. Protein hinders enzyme: It can hinder the proliferation of leukemia cells. Anti (slow) digestible starch has the effect of preventing rapid rise of blood sugar and weight loss. A survey of 850 Yi people showed that eating 100 grams of tartary buckwheat flour per day can reduce cholesterol and low-density lipoprotein. 62 Chinese patients with type Ⅱ diabetes drink 6 grams of tartary buckwheat hypoglycemic tea every day. After 18 months, the effect of reducing fasting and postprandial blood sugar is obvious, and the total effect and effectiveness account for 90.32%. Constipation patients and ordinary people consume buckwheat tea for 7-10 days, and they can go to the toilet easily.
苦荞是集“营养、保健、医疗”于一体的天然功能食品。我国古籍中关于苦荞麦防病治病的记载。《齐民要术》有“头风畏冷者,以面汤和粉为饼,更令罨出汗,虽数十年亦愈”。《图经本草》有“实肠胃,益气力”的记载。《本草纲木》有“降气宽肠磨积滞,消热肿风痛,除白浊血滞,脾积泄泻”的论述。记载苦荞麦性味苦、平、寒,有益气力、续精神、利耳目、降气宽肠健胃的作用。《植物名实图考》称荞麦“性能消积,俗呼净肠草”。苦荞能降血压、降血糖、降血脂,改善微循环等作用,又称“三降”食品。Tartary buckwheat is a natural functional food integrating "nutrition, health care and medical treatment". There are records about the prevention and treatment of tartary buckwheat in ancient books of our country. "Qi Min Yao Shu" has "Those who are afraid of the cold in the head, use noodle soup and noodles as cakes, which will make him sweat even after decades." "Tu Jing Materia Medica" has a record of "strengthening the stomach and benefiting energy". "Compendium of Materia Medica" has the discussion of "lowering Qi, widening intestinal grinding and stagnation, reducing heat, swelling and pain, removing white turbid blood stagnation, spleen accumulation and diarrhea". It is recorded that tartary buckwheat is bitter, flat and cold in nature and taste, beneficial to strength, sustaining spirit, benefiting eyes and ears, lowering qi, widening intestines and strengthening stomach. "Plant Names and Facts" says that buckwheat "can eliminate accumulation, commonly known as grass for purifying intestines". Tartary buckwheat can lower blood pressure, lower blood sugar, lower blood fat, improve microcirculation, etc., also known as "three lowering" food.
哈尔滨医科大学公共卫生学院一项调查表明,主食荞麦地区的人群,其血糖水平和糖尿病患病率明显低于不食用荞麦地区的人群。其中,主食荞麦的居民高血糖水平(即高于正常值的血糖水平)的检出率为1.6%;而非主食荞麦的人群,高血糖的检出率为7.33%,后者高于前者近4倍。主食荞麦和不食用荞麦地区的糖尿病患病率也相差约1倍,前者为1.88%,后者为3.84%。这一结论提示,荞麦作为有效降低糖尿病发生的杂粮作物,应该更多地出现在老百姓的餐桌上。A survey by the School of Public Health of Harbin Medical University showed that people in areas where buckwheat is the staple food have significantly lower blood sugar levels and diabetes prevalence than those in areas where buckwheat is not eaten. Among them, the detection rate of high blood sugar level (that is, blood sugar level higher than the normal value) was 1.6% among residents who ate buckwheat as a staple food; the detection rate of high blood sugar level was 7.33% among residents who did not eat buckwheat as a staple food, and the latter was nearly higher than the former 4 times. The prevalence of diabetes in areas where the staple food buckwheat is eaten and where the buckwheat is not eaten is also about 1 times different, the former is 1.88%, and the latter is 3.84%. This conclusion suggests that buckwheat, as a multigrain crop that can effectively reduce the occurrence of diabetes, should appear more on the table of ordinary people.
动物实验表明,苦荞类黄酮可以使高血脂小鼠的甘油三酯水平和高血脂大鼠的胆固醇及甘油三酯水平明显降低;但是它不降低二者的高密度脂蛋白水平,因此苦荞类黄酮具有降血脂作用。另外生的苦荞需要经过适当的烘培加工后才可做茶饮用,但是苦荞的烘培工艺要求较高,很容易炒过炒糊,或者炒的火候不到,破坏苦荞的有效成份,影响口感以及芦丁的渗出率。这是因为苦荞生物类黄酮中所富含的槲皮素等能降低甘油三酯和总胆固醇含量,减少动脉粥样硬化指数。Animal experiments have shown that tartary buckwheat flavonoids can significantly reduce the levels of triglycerides in mice with hyperlipidemia and the levels of cholesterol and triglycerides in rats with hyperlipidemia; Flavonoids have a hypolipidemic effect. In addition, the raw tartary buckwheat needs to be roasted and processed properly before it can be used as tea. However, the baking process of tartary buckwheat is relatively high, and it is easy to over-fry it, or the frying temperature is not enough, which will destroy the active ingredients of tartary buckwheat. , affecting the taste and the exudation rate of rutin. This is because quercetin, which is rich in tartary buckwheat bioflavonoids, can reduce triglycerides and total cholesterol, and reduce atherosclerosis index.
苦荞麦中富含的生物类黄酮主要成分是芦丁,又名VP,其主要功效是软化血管,改善微循环,清热解毒、活血化瘀、拔毒生肌、益气提神,有降血糖和尿糖的作用。荷兰米切尔·赫托格牡博士对805名老年男性膳食中生物类黄酮的含量进行了测定,结果发现,每天摄入生物类黄酮的量不小于30mg的组,比每天摄入生物类黄酮量不大于19mg的组,死于冠心病的危险性降低了50%。镁对心肌活动有良好调节作用,可使心脏节律及心奋传导减缓,增加心肌供血量,有利心脏舒张和休息。苦荞麦中的镁含量是小麦粉的11倍以上。The main component of bioflavonoids rich in tartary buckwheat is rutin, also known as VP. Its main functions are to soften blood vessels, improve microcirculation, clear away heat and detoxify, activate blood circulation and remove blood stasis, pull out toxins and generate muscle, replenish qi and refresh the mind, and have the effect of lowering blood sugar and The role of urine sugar. Dr. Mitchell Hertogmu of the Netherlands measured the content of bioflavonoids in the diet of 805 elderly men, and found that the group whose daily intake of bioflavonoids was not less than 30mg had a greater The risk of dying from coronary heart disease was reduced by 50% in the group whose dose was not more than 19mg. Magnesium has a good regulating effect on myocardial activity, which can slow down the heart rhythm and cardiac conduction, increase the blood supply to the myocardium, and benefit the heart to relax and rest. The magnesium content in tartary buckwheat is more than 11 times that of wheat flour.
苦荞生物类黄酮具有多方面的生理功能,其中的槲皮素和桑色素等能够改善机体血管平滑肌的收缩和舒张功能;芦丁具有扩张血管的作用,能维持毛细血管的抵抗力,降低其通透性及脆性,促进细胞增生和防止血细胞的凝集,还有降血脂、扩张冠状动脉、增强冠状动脉血流量等作用。荞麦粉中所含丰富的维生素有降低人体血脂和胆固醇的作用,是治疗高血压和心血管病的重要辅助食(药)物。荞麦粉中含有的一些微量元素(如镁、铁、铜、钾等)对于心血管具有保护作用。Tartary buckwheat bioflavonoids have various physiological functions, among which quercetin and morin can improve the contraction and relaxation of vascular smooth muscle; rutin has the effect of dilating blood vessels, can maintain the resistance of capillaries, and reduce Permeability and fragility, promoting cell proliferation and preventing blood cell agglutination, as well as lowering blood lipids, dilating coronary arteries, and enhancing coronary blood flow. The rich vitamins contained in buckwheat flour have the effect of lowering blood fat and cholesterol in human body, and it is an important supplementary food (drug) for treating hypertension and cardiovascular disease. Some trace elements (such as magnesium, iron, copper, potassium, etc.) contained in buckwheat flour have a protective effect on cardiovascular.
研究证实,苦荞生物类黄酮所富含的槲皮素、桑色素、莰非醇有抑菌和抗病毒作用。临床应用该黄酮,对各种原因引起的溃疡有祛腐生肌、消炎镇痛的奇特疗效。Studies have confirmed that quercetin, morin, and camphenol, which are rich in tartary buckwheat bioflavonoids, have antibacterial and antiviral effects. The clinical application of this flavonoid has unique curative effects on ulcers caused by various reasons, such as removing putrefaction and promoting granulation, reducing inflammation and relieving pain.
自由基(free radical)是引起癌症、衰老、心脑血管退变性疾病的罪恶之源。因为苦荞类黄酮物质易被氧化,才使其具有清除自由基的功能。苦荞生物类黄酮组成的分子结构符合有效酚羟基理论,具有极强的自由基清除能力,它们具有5个羟基,可以充足地作为供氢体,使自由基还原,从而起到清除自由基的作用,达到防衰、抗癌,抗心脑血管病的目的。护肝作用苦荞生物类黄酮对急慢性肝炎、肝硬化、脂肪肝,以及因半乳糖胺和CCl4等引起的中毒性肝损伤均有一定的疗效。研究表明,苦荞生物类黄酮对CCl4所致肝脏丙二醛(MDA肝脂质过氧化终产物)含量的增高有明显的抑制作用;可减轻肝损伤对谷光甘肽(GSH)的消耗;能够保护细胞结构的完整性,防止肝细胞中的转氨酶等可溶性酶因从细胞中漏出而活性升高。苦荞生物类黄酮的护肝机制最终在于它的抗氧化和抗自由基的作用。Free radicals are the source of evils that cause cancer, aging, and cardiovascular and cerebrovascular degenerative diseases. Because tartary buckwheat flavonoids are easily oxidized, it has the function of scavenging free radicals. The molecular structure of tartary buckwheat bioflavonoids conforms to the theory of effective phenolic hydroxyl groups, and has a strong ability to scavenge free radicals. They have 5 hydroxyl groups, which can be fully used as hydrogen donors to reduce free radicals, thereby playing a role in scavenging free radicals. It can achieve the purpose of anti-aging, anti-cancer, and anti-cardiovascular and cerebrovascular diseases. Hepatoprotective effect Tartary buckwheat bioflavonoids have a certain curative effect on acute and chronic hepatitis, liver cirrhosis, fatty liver, and toxic liver damage caused by galactosamine and CCl4. Studies have shown that tartary buckwheat bioflavonoids have a significant inhibitory effect on the increase of liver malondialdehyde (MDA hepatic lipid peroxidation end product) caused by CCl4; can reduce the consumption of glutathione (GSH) by liver damage; can Protect the integrity of cell structure and prevent the activity of soluble enzymes such as transaminase in liver cells from increasing due to leakage from cells. The hepatoprotective mechanism of tartary buckwheat bioflavonoids ultimately lies in its antioxidant and anti-free radical effects.
马铃薯,属茄科多年生草本植物,块茎可供食用,是全球第三大重要的粮食作物,仅次于小麦和玉米。马铃薯又称地蛋、土豆、洋山芋等,茄科植物的块茎。与小麦、玉米、稻谷、高粱并成为世界五大作物。Potato, a perennial herb belonging to the family Solanaceae, has edible tubers and is the third most important food crop in the world, second only to wheat and corn. Potatoes are also called ground eggs, potatoes, potatos, etc., the tubers of Solanaceae plants. Together with wheat, corn, rice, and sorghum, it has become the world's top five crops.
一般新鲜马铃薯中所含成分:淀粉9~20%,蛋白质1.5~2.3%,脂肪0.1~1.1%,粗纤维0.6~0.8%。100g马铃薯中所含的营养成分:能量318千焦,钙5~8mg,磷15~40mg,铁0.4mg~0.8mg,钾200~340mg,碘0.8~1.2,胡萝卜素12~30mg,硫胺素0.03~0.08mg,核黄素0.01~0.04mg,尼克酸0.4~1.1mg。The ingredients contained in general fresh potatoes: starch 9-20%, protein 1.5-2.3%, fat 0.1-1.1%, crude fiber 0.6-0.8%. Nutrients contained in 100g potatoes: energy 318 kJ, calcium 5-8mg, phosphorus 15-40mg, iron 0.4mg-0.8mg, potassium 200-340mg, iodine 0.8-1.2, carotene 12-30mg, thiamine 0.03~0.08mg, riboflavin 0.01~0.04mg, nicotinic acid 0.4~1.1mg.
马铃薯块茎含有大量的淀粉。淀粉是食用马铃薯的主要能量来源。一般早熟种马铃薯含有11%~14%的淀粉,中晚熟种含有14%~20%的淀粉,高淀粉品种的块茎可达25%以上。块茎还含有葡萄糖、果糖和蔗糖等。马铃薯蛋白质营养价值高,马铃薯块茎含有2%左右的蛋白质,薯干中蛋白质含量为8%~9%。据研究,马铃薯的蛋白质营养价值很高,其品质相当于鸡蛋的蛋白质,容易消化、吸收,优于其他作物的蛋白质。而且马铃薯的蛋白质含有18种氨基酸,包括人体不能合成的各种必需氨基酸。高度评价马铃薯的营养价值,是与其块茎含有高品位的蛋白质和必需氨基酸的赖氨酸、色氨酸、组氨酸、精氨酸、苯丙氨酸、缬氨酸、亮氨酸、异亮氨酸和蛋氨酸的存在是分不开的。马铃薯块茎含有多种维生素和无机盐。食用马铃薯有益于健康与维生素的作用是分不开的。特别是维生素C可防止坏血病,刺激造血机能等,在日常吃的大米、白面中是没有的,而马铃薯可提供大量的维生素c。块茎中还含有维生素A(胡萝卜素)、维生素B1,(硫胺素)、维生素B2(核黄素)、维生素pp(烟酸)、维生素E(生育酚)、维生素B3(泛酸)、维生素B6(吡哆醇)、维生素M(叶酸)和生物素H等,对人体健康都是有益的。此外,块茎中的无机盐如钙、磷、铁、钾、钠、锌,锰等,也是对人的健康和幼儿发育成长不可缺少的元素。马铃薯块茎中含有丰富的膳食纤维,并含有丰富的钾盐,属于碱性食品。有资料表示,其含量与苹果一样多。因此胃肠对马铃薯的吸收较慢,食用马铃薯后,停留在肠道中的时间比米饭长的多,所以更具有饱腹感,同时还能帮助带走一些油脂和垃圾,具有一定的通便排毒作用。除此以外,马铃薯的块茎还含有禾谷类粮食中所没有的胡萝卜素和抗坏血酸。从营养角度来看,它比大米、面粉具有更多的优点,能供给人体大量的热能,可称为“十全十美的食物”。人如果只靠马铃薯和全脂牛奶就足以维持生命和健康。因为马铃薯的营养成分非常全面,营养结构也较合理,只是蛋白质、钙和维生素A的量稍低;而这正好用全脂牛奶来补充。马铃薯块茎水分多、脂肪少、单位体积的热量相当低,所含的维生素C是苹果的4倍左右,B族维生素是苹果的4倍,各种矿物质是苹果的几倍至几十倍不等,马铃薯是降血压食物,膳食中某种营养多了或缺了可致病。同样道理,调整膳食,也就可以“吃”掉相应疾病。马铃薯具有抗衰老的功效,它含有丰富的维生素B1、B2、B6和泛酸等B族维生素及大量的优质纤维素,还含有微量元素、氨基酸、蛋白质、脂肪和优质淀粉等营养元素。马铃薯是碳水化合物,但是其含量仅是同等重量大米的1/4左右,研究表明,马铃薯中的淀粉是一种抗性淀粉,具有缩小脂肪细胞的作用。马铃薯是非常好的高钾低钠食品,很适合水肿型肥胖者食用,加上其钾含量丰富,几乎是蔬菜中最高的,所以还具有瘦腿的功效。由此可知,马铃薯具有很高的营养价值和药用价值,因此,马铃薯被广泛制作成各种各样的产品。Potato tubers contain a lot of starch. Starch is the main source of energy for eating potatoes. Generally, early-maturing potatoes contain 11% to 14% starch, mid-to-late-maturing potatoes contain 14% to 20% starch, and high-starch tubers can reach more than 25%. Tubers also contain glucose, fructose and sucrose etc. The nutritional value of potato protein is high. Potato tubers contain about 2% protein, and the protein content in dried potatoes is 8% to 9%. According to research, the nutritional value of potato protein is very high, and its quality is equivalent to that of eggs. It is easy to digest and absorb, and is better than protein from other crops. Moreover, potato protein contains 18 kinds of amino acids, including various essential amino acids that cannot be synthesized by the human body. Potatoes are highly evaluated for their nutritional value, and their tubers contain high-grade protein and essential amino acids lysine, tryptophan, histidine, arginine, phenylalanine, valine, leucine, and isoleucine The presence of amino acid and methionine are inseparable. Potato tubers contain various vitamins and inorganic salts. The health benefits of eating potatoes are inseparable from the role of vitamins. In particular, vitamin C can prevent scurvy, stimulate hematopoietic function, etc., which is not found in the rice and white noodles eaten daily, and potatoes can provide a large amount of vitamin C. Tubers also contain vitamin A (carotene), vitamin B1, (thiamine), vitamin B2 (riboflavin), vitamin pp (niacin), vitamin E (tocopherol), vitamin B3 (pantothenic acid), vitamin B6 (pyridoxine), vitamin M (folic acid) and biotin H, etc., are beneficial to human health. In addition, inorganic salts in tubers such as calcium, phosphorus, iron, potassium, sodium, zinc, manganese, etc. are also indispensable elements for human health and child development and growth. Potato tubers are rich in dietary fiber and rich in potassium salts, which are alkaline foods. Some data indicate that its content is as much as that of apples. Therefore, the gastrointestinal absorption of potatoes is slow. After eating potatoes, they stay in the intestines for a longer time than rice, so they feel fuller. At the same time, they can help take away some fat and garbage, and have a certain degree of laxative detoxification. effect. In addition, potato tubers also contain carotene and ascorbic acid that are not found in cereal grains. From a nutritional point of view, it has more advantages than rice and flour, and can supply a large amount of heat energy to the human body. It can be called "perfect food". Potatoes and whole milk alone are sufficient for life and health. Because the nutritional content of potatoes is very comprehensive, and the nutritional structure is relatively reasonable, but the amount of protein, calcium and vitamin A is slightly lower; and this is just supplemented by whole milk. Potato tubers have more water, less fat, and relatively low calories per unit volume. The vitamin C contained in potato tubers is about 4 times that of apples, the B vitamins are 4 times that of apples, and various minerals are several to dozens of times that of apples. Etc. Potatoes are a food for lowering blood pressure. Excess or lack of certain nutrients in the diet can cause disease. In the same way, adjusting the diet can also "eat" the corresponding diseases. Potatoes have anti-aging effects. They are rich in B vitamins such as vitamins B1, B2, B6 and pantothenic acid, and a large amount of high-quality cellulose. They also contain nutrients such as trace elements, amino acids, proteins, fats and high-quality starch. Potatoes are carbohydrates, but their content is only about 1/4 of the same weight of rice. Studies have shown that the starch in potatoes is a kind of resistant starch, which can shrink fat cells. Potato is a very good high-potassium and low-sodium food, which is very suitable for edema-type obesity. In addition, its potassium content is rich, almost the highest among vegetables, so it also has the effect of thinning legs. It can be seen that potatoes have high nutritional value and medicinal value, therefore, potatoes are widely made into various products.
目前,关于马铃薯和苦荞的产品较多,但是基于苦荞马铃薯汁液干燥物混合口含片目前还没有相关报道。At present, there are many products about potatoes and tartary buckwheat, but there is no relevant report on the mixed buccal tablets based on tartary buckwheat potato juice dry matter.
发明内容Contents of the invention
本发明所解决的技术问题是提供一种能够制得营养价值较高的口含片的苦荞马铃薯汁液干燥物混合口含片的制备方法。The technical problem to be solved by the present invention is to provide a preparation method for buccal tablets mixed with tartary buckwheat and potato juice dry matter which can produce buccal tablets with high nutritional value.
本发明解决上述技术问题所采用的技术方案是:该苦荞马铃薯汁液干燥物混合口含片的制备方法,包括以下步骤:The technical solution adopted by the present invention to solve the above-mentioned technical problems is: the preparation method of the tartary buckwheat potato juice dry matter mixed buccal tablet, comprising the following steps:
步骤一、将苦荞粉与清水按照如下所述重量比混合得到苦荞液体,所述苦荞粉与清水的重量比为1:(5~20);Step 1, mix tartary buckwheat powder and clear water according to the following weight ratio to obtain tartary buckwheat liquid, the weight ratio of the tartary buckwheat powder and clear water is 1: (5-20);
步骤二、向步骤一得到的苦荞液体中加入复合蛋白酶进行酶解处理;Step 2, adding composite protease to the tartary buckwheat liquid obtained in step 1 to carry out enzymolysis treatment;
步骤三、将经过酶解处理的苦荞液体静置后取上清液,并将上清液进行喷雾干燥处理或真空浓缩处理得到苦荞粉状物;Step 3, taking the supernatant after the tartary buckwheat liquid treated by enzymolysis is allowed to stand, and subjecting the supernatant to spray-drying treatment or vacuum concentration treatment to obtain tartary buckwheat powder;
步骤四、制备马铃薯汁,并将马铃薯汁进行喷雾干燥处理或真空浓缩处理得到马铃薯粉状物;Step 4, preparing potato juice, and subjecting the potato juice to spray drying or vacuum concentration to obtain potato powder;
步骤五、将步骤三得到的苦荞粉状物以及步骤四得到的马铃薯粉状物与芦丁粉、马铃薯粉按照一定比例混合得到基料,各组分的重量配比如下:苦荞粉状物0-20%,芦丁粉1-10%,马铃薯粉状物30%-60%,余量为马铃薯粉;Step 5. Mix the tartary buckwheat powder obtained in step 3 and the potato powder obtained in step 4 with rutin powder and potato powder according to a certain ratio to obtain the base material. The weight ratio of each component is as follows: tartary buckwheat powder 0-20% of rutin powder, 1-10% of rutin powder, 30%-60% of potato powder, and the balance is potato powder;
步骤六、将基料按照常规口含片的制作工艺制成口含片。Step 6, the base material is made into a buccal tablet according to a conventional buccal tablet manufacturing process.
进一步的是,所述马铃薯粉由马铃薯熟粉、马铃薯生粉混合而成,所述马铃薯熟粉与马铃薯生粉的比例为1:(0.8~9)。Further, the potato flour is prepared by mixing cooked potato flour and raw potato flour, and the ratio of cooked potato flour to raw potato flour is 1: (0.8-9).
进一步的是,在步骤二中,所述复合蛋白酶由胃蛋白酶、胰蛋白酶、组织蛋白酶、木瓜蛋白酶和枯草杆菌蛋白酶混合而成,所述酶解处理的pH为8.0、温度为37℃,酶解时间为24小时。Further, in step 2, the composite protease is formed by mixing pepsin, trypsin, cathepsin, papain and subtilisin, the pH of the enzymolysis treatment is 8.0, and the temperature is 37°C. The time is 24 hours.
进一步的是,所述马铃薯熟粉为马铃薯全粉。Further, the cooked potato flour is whole potato flour.
进一步的是,所述马铃薯熟粉为由马铃薯生粉经过挤压膨化得到的马铃薯挤压膨化粉。Further, the cooked potato flour is extruded and expanded potato flour obtained from raw potato flour through extrusion.
进一步的是,所述马铃薯生粉为马铃薯淀粉。Further, the raw potato flour is potato starch.
进一步的是,所述马铃薯生粉采用如下方法制备:将新鲜的马铃薯清洗干净后晒干并粉碎成粉末状清洗。Further, the raw potato powder is prepared by the following method: fresh potatoes are washed, dried in the sun, crushed into powder and washed.
进一步的是,所述马铃薯生粉和马铃薯汁采用如下方法加工而成,具体方法如下所述:Further, the raw potato flour and potato juice are processed by the following method, and the specific method is as follows:
A、选取新鲜的马铃薯并将其进行清洗、去皮处理;A, select fresh potatoes and clean and peel them;
B、将清洗去皮的马铃薯放入清水中并将其捣碎成马铃薯浆液,所述马铃薯与清水的重量比为1:(0.2~05);B. Putting the cleaned and peeled potatoes into clear water and mashing them into potato slurry, the weight ratio of the potatoes to clear water is 1: (0.2-05);
C、在步骤B得到的马铃薯浆液中加入果胶酶和亚硫酸钠,在温度为45-55℃、PH值为3-4的条件下反应1-2小时,所述马铃薯浆液与果胶酶的重量比为1:(0.0001~0.0002),所述马铃薯浆液与果胶酶硫酸钠的重量比为1:(0.00015~0.00025);C. Add pectinase and sodium sulfite to the potato slurry obtained in step B, and react for 1-2 hours at a temperature of 45-55° C. and a pH value of 3-4. The weight of the potato slurry and pectinase The ratio is 1:(0.0001~0.0002), and the weight ratio of the potato slurry to pectinase sodium sulfate is 1:(0.00015~0.00025);
D、将经过步骤C处理得到的马铃薯浆液进行固液分离得到马铃薯汁与马铃薯颗粒沉淀;D. Solid-liquid separation is performed on the potato slurry obtained through step C to obtain potato juice and potato particle precipitation;
E、将马铃薯颗粒沉淀低温烘干或晒干后粉碎得到马铃薯生粉。E. Precipitating potato granules is dried at low temperature or sun-dried, and then pulverized to obtain potato starch.
进一步的是,所述马铃薯生粉和马铃薯汁采用如下方法加工而成,具体方法如下所述:Further, the raw potato flour and potato juice are processed by the following method, and the specific method is as follows:
a、选取新鲜的马铃薯并将其进行清洗、去皮处理;a, select fresh potatoes and clean and peel them;
b、将清洗去皮的马铃薯进行压榨处理得到马铃薯汁和马铃薯榨干物;b. Pressing the cleaned and peeled potatoes to obtain potato juice and dried potatoes;
c、将步骤b得到的马铃薯榨干物低温烘干或晒干后粉碎得到马铃薯生粉。c. The dried potato product obtained in step b is dried at low temperature or dried in the sun, and then pulverized to obtain potato starch.
进一步的是,所述芦丁粉采用如下方法得到,具体方法如下所述:Further, the rutin powder is obtained by the following method, and the specific method is as follows:
S1、选取完整的苦荞籽并清洗干净;S1, choose the complete tartary buckwheat seeds and clean them;
S2、将清洗干净的苦荞籽放入清水中,在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105-110℃的环境中进行烘干处理,烘干时间为20-200分钟;S2. Put the cleaned tartary buckwheat seeds into clean water, soak them for 2-24 hours at 10-50°C, drain the tartary buckwheat seeds after soaking, and then place the drained tartary buckwheat seeds Carry out drying treatment in an environment of -110°C, and the drying time is 20-200 minutes;
S3、将烘干后的苦荞籽放入盛装有碱性溶液的容器中,所述苦荞籽与碱性溶液的重量比为1:(5-20),所述碱性溶液的pH值为8~9,温度为90℃,然后将密封的容器放入超声波环境中进行超声波恒温浸提,所述超声波恒温浸提的时间为10-40min,所述超声波恒温浸提的温度为60-90℃,浸提结束后将密封的容器取出并冷却;S3. Put the dried tartary buckwheat seeds into a container filled with an alkaline solution, the weight ratio of the tartary buckwheat seeds to the alkaline solution is 1: (5-20), and the pH value of the alkaline solution is 8 to 9, the temperature is 90°C, and then the sealed container is placed in an ultrasonic environment for ultrasonic constant temperature leaching. The time of the ultrasonic constant temperature leaching is 10-40min, and the temperature of the ultrasonic constant temperature leaching is 60- 90°C, take out the sealed container after leaching and cool it down;
S4、对容器中的液体进行抽滤处理,得到苦荞浸提液与浸提过后的苦荞籽,并将浸提过后的苦荞籽进行干燥处理;S4, performing suction filtration on the liquid in the container to obtain tartary buckwheat extract and leached tartary buckwheat seeds, and drying the leached tartary buckwheat seeds;
S5、在步骤S4得到的苦荞浸提液中加入酸性溶液调节混合液体的pH值至3.5-4,然后静置得到芦丁沉淀物,并对芦丁沉淀物进行干燥得到芦丁粉。S5, adding an acidic solution to the tartary buckwheat extract obtained in step S4 to adjust the pH value of the mixed liquid to 3.5-4, then standing still to obtain rutin precipitate, and drying the rutin precipitate to obtain rutin powder.
本发明的有益效果:本发明所述的苦荞马铃薯汁液干燥物混合口含片的制备方法先将苦荞粉与清水按照一定比例混合得到苦荞液体,然后在苦荞液体中加入复合蛋白酶进行酶解处理;接着将经过酶解处理的苦荞液体静置后取上清液,并将上清液进行喷雾干燥处理或真空浓缩处理得到苦荞粉状物,再将马铃薯汁进行喷雾干燥处理或真空浓缩处理得到马铃薯粉状物;最后将得到的苦荞粉状物、马铃薯粉状物与芦丁粉、马铃薯粉按照一定比例混合得到基料,并将基料按照常规口含片的制作工艺制成口含片,利用该方法可以制得一种高含量苦荞、芦丁和马铃薯的口含片,其营养价值较高,可以作为一种保健食品,经常服用可以大大提高人们的身体素质。Beneficial effects of the present invention: the preparation method of the tartary buckwheat potato juice dried product mixed buccal tablet firstly mixes tartary buckwheat powder and clear water according to a certain ratio to obtain tartary buckwheat liquid, and then adds complex protease to the tartary buckwheat liquid Enzyme hydrolysis treatment; then put the tartary buckwheat liquid that has been enzymatically treated to stand still, take the supernatant, and spray-dry the supernatant or vacuum concentrate to obtain tartary buckwheat powder, and then spray-dry the potato juice or vacuum concentration treatment to obtain potato powder; finally, the obtained tartary buckwheat powder, potato powder, rutin powder, and potato powder are mixed according to a certain ratio to obtain the base material, and the base material is made according to the conventional buccal tablet The buccal tablet is made by technology, and a buccal tablet with high content of tartary buckwheat, rutin and potato can be prepared by using this method. It has high nutritional value and can be used as a health food. Regular consumption can greatly improve people's health. Quality.
具体实施方式detailed description
该苦荞马铃薯汁液干燥物混合口含片的制备方法,包括以下步骤:The preparation method of the tartary buckwheat potato juice dried product mixed buccal tablet comprises the following steps:
步骤一、将苦荞粉与清水按照如下所述重量比混合得到苦荞液体,所述苦荞粉与清水的重量比为1:(5~20);Step 1, mix tartary buckwheat powder and clear water according to the following weight ratio to obtain tartary buckwheat liquid, the weight ratio of the tartary buckwheat powder and clear water is 1: (5-20);
步骤二、向步骤一得到的苦荞液体中加入复合蛋白酶进行酶解处理;Step 2, adding composite protease to the tartary buckwheat liquid obtained in step 1 to carry out enzymolysis treatment;
步骤三、将经过酶解处理的苦荞液体静置后取上清液,并将上清液进行喷雾干燥处理或真空浓缩处理得到苦荞粉状物;Step 3, taking the supernatant after the tartary buckwheat liquid treated by enzymolysis is allowed to stand, and subjecting the supernatant to spray-drying treatment or vacuum concentration treatment to obtain tartary buckwheat powder;
步骤四、制备马铃薯汁,并将马铃薯汁进行喷雾干燥处理或真空浓缩处理得到马铃薯粉状物;Step 4, preparing potato juice, and subjecting the potato juice to spray drying or vacuum concentration to obtain potato powder;
步骤五、将步骤三得到的苦荞粉状物以及步骤四得到的马铃薯粉状物与芦丁粉、马铃薯粉按照一定比例混合得到基料,各组分的重量配比如下:苦荞粉状物0-20%,芦丁粉1-10%,马铃薯粉状物30%-60%,余量为马铃薯粉;Step 5. Mix the tartary buckwheat powder obtained in step 3 and the potato powder obtained in step 4 with rutin powder and potato powder according to a certain ratio to obtain the base material. The weight ratio of each component is as follows: tartary buckwheat powder 0-20% of rutin powder, 1-10% of rutin powder, 30%-60% of potato powder, and the balance is potato powder;
步骤六、将基料按照常规口含片的制作工艺制成口含片。Step 6, the base material is made into a buccal tablet according to a conventional buccal tablet manufacturing process.
本发明所述的苦荞马铃薯汁液干燥物混合口含片的制备方法先将苦荞粉与清水按照一定比例混合得到苦荞液体,然后在苦荞液体中加入复合蛋白酶进行酶解处理;接着将经过酶解处理的苦荞液体静置后取上清液,并将上清液进行喷雾干燥处理或真空浓缩处理得到苦荞粉状物,再将马铃薯汁进行喷雾干燥处理或真空浓缩处理得到马铃薯粉状物;最后将得到的苦荞粉状物、马铃薯粉状物与芦丁粉、马铃薯粉按照一定比例混合得到基料,并将基料按照常规口含片的制作工艺制成口含片,利用该方法可以制得一种高含量苦荞、芦丁和马铃薯的口含片,其营养价值较高,可以作为一种保健食品,经常服用可以大大提高人们的身体素质。The preparation method of tartary buckwheat potato juice dried product mixed buccal tablet of the present invention first mixes tartary buckwheat powder and clear water according to a certain ratio to obtain tartary buckwheat liquid, then adds compound protease to the tartary buckwheat liquid for enzymolysis treatment; then The tartary buckwheat liquid treated by enzymolysis is left to stand, and the supernatant is taken, and the supernatant is spray-dried or vacuum-concentrated to obtain tartary buckwheat powder, and then the potato juice is spray-dried or vacuum-concentrated to obtain potatoes Powder; finally, the obtained tartary buckwheat powder, potato powder, rutin powder, and potato powder are mixed according to a certain ratio to obtain a base material, and the base material is made into a buccal tablet according to a conventional buccal tablet manufacturing process A buccal tablet with high content of tartary buckwheat, rutin and potato can be prepared by using the method, which has high nutritional value and can be used as a health food. Regular consumption can greatly improve people's physical fitness.
添加芦丁粉主要是为了提高口含片的营养价值,芦丁属维生素类药,有降低毛细血管通透性和脆性的作用,保持及恢复毛细血管的正常弹性。用于防治高血压脑溢血;糖尿病视网膜出血和出血性紫癜等,也用作食品抗氧剂和色素。芦丁还是合成曲克芦丁的主要原料,曲克芦丁为心脑血管用药,能有效抑制血小板的聚集,有防止血栓形成的作用。芦丁粉的添加量可以是1.0%、1.1%、1.2%、1.3%、1.4%、1.5%、2.5%、3%、3.5%、4%、4.5%、5%、6%、7%、8%、9%、10%,芦丁粉的含量越高越好,但是为了控制成型米成本,所述芦丁粉的添加量优选为4.4%即可。Adding rutin powder is mainly to improve the nutritional value of buccal tablets. Rutin is a vitamin drug that can reduce the permeability and fragility of capillaries, and maintain and restore the normal elasticity of capillaries. It is used to prevent and treat hypertensive cerebral hemorrhage; diabetic retinal hemorrhage and hemorrhagic purpura, etc. It is also used as food antioxidant and pigment. Rutin is also the main raw material for the synthesis of troxerutin. Troxerutin is a cardiovascular and cerebrovascular medicine, which can effectively inhibit the aggregation of platelets and prevent thrombosis. The amount of rutin powder added can be 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 6%, 7%, 8%, 9%, 10%, the higher the content of the rutin powder, the better, but in order to control the cost of molded rice, the added amount of the rutin powder is preferably 4.4%.
所述苦荞粉状物的含量可以是5%、10%、15%、20%,马铃薯粉状物的含量可以是30%、35%、40%、45%、50%、55%、60%。The content of the buckwheat powder can be 5%, 10%, 15%, 20%, and the content of the potato powder can be 30%, 35%, 40%, 45%, 50%, 55%, 60% %.
为了便于口含片的后续加工,所述马铃薯粉由马铃薯熟粉、马铃薯生粉混合而成,所述马铃薯熟粉与马铃薯生粉的比例为1:(0.8~9),该比例混合而成的马铃薯粉不但具有很好的加工特性,同时马铃薯粉所具有的营养物质也较为全面。所述马铃薯熟粉与马铃薯生粉的比例可以为1:0.8,1:1.8,1:2.8,1:3.8,1:4.8,1:5.8,1:6.8,1:7.8,1:9。In order to facilitate the subsequent processing of buccal tablets, the potato flour is mixed with cooked potato flour and raw potato flour. The ratio of cooked potato flour to raw potato flour is 1: (0.8-9), and the ratio is mixed High-quality potato flour not only has good processing characteristics, but also has comprehensive nutrients. The ratio of the cooked potato flour to the raw potato flour can be 1:0.8, 1:1.8, 1:2.8, 1:3.8, 1:4.8, 1:5.8, 1:6.8, 1:7.8, 1:9.
另外,在步骤二中,所述复合蛋白酶由胃蛋白酶、胰蛋白酶、组织蛋白酶、木瓜蛋白酶和枯草杆菌蛋白酶混合而成,所述酶解处理的pH为8.0、温度为37℃,酶解时间为24小时。该复合蛋白酶可以将苦荞粉完全分解,从而释放出苦荞中含有的各种营养物质,从而使得上清液中含有的营养物质种类和含量都较多,可以大大提高粉状物的营养物质含量。所述复合蛋白酶的添加量为苦荞重量液体的(0.2-0.8)%。In addition, in step 2, the composite protease is formed by mixing pepsin, trypsin, cathepsin, papain and subtilisin, the pH of the enzymolysis treatment is 8.0, the temperature is 37°C, and the enzymolysis time is 24 hours. The complex protease can completely decompose the buckwheat powder, thereby releasing various nutrients contained in the buckwheat, so that the types and contents of the nutrients contained in the supernatant are more, which can greatly improve the nutrients of the powder content. The added amount of the composite protease is (0.2-0.8)% of the weight of the tartary buckwheat liquid.
所述马铃薯熟粉可以为马铃薯全粉,也可以是由马铃薯生粉经过挤压膨化得到的马铃薯挤压膨化粉。The cooked potato flour can be whole potato flour, or extruded potato flour obtained by extruding raw potato flour.
所述马铃薯生粉可以为马铃薯淀粉。所述马铃薯生粉也可以采用如下方法制备:将新鲜的马铃薯清洗干净后晒干并粉碎成粉末状清洗。该方法制备得到的马铃薯生粉保留了马铃薯全部的营养物质,而且加工步骤简单,成本非常低,大大降低了加工成本。The potato starch can be potato starch. The raw potato powder can also be prepared by the following method: fresh potatoes are washed, dried in the sun, crushed into powder and washed. The raw potato flour prepared by the method retains all the nutrients of the potato, has simple processing steps, and has very low cost, thereby greatly reducing the processing cost.
所述马铃薯生粉和马铃薯汁采用如下方法加工而成,具体方法如下所述:Described raw potato flour and potato juice are processed by the following method, and the specific method is as follows:
A、选取新鲜的马铃薯并将其进行清洗、去皮处理;A, select fresh potatoes and clean and peel them;
B、将清洗去皮的马铃薯放入清水中并将其捣碎成马铃薯浆液,所述马铃薯与清水的重量比为1:(0.2~05);B. Putting the cleaned and peeled potatoes into clear water and mashing them into potato slurry, the weight ratio of the potatoes to clear water is 1: (0.2-05);
C、在步骤B得到的马铃薯浆液中加入果胶酶和亚硫酸钠,在温度为45-55℃、PH值为3-4的条件下反应1-2小时,所述马铃薯浆液与果胶酶的重量比为1:(0.0001~0.0002),所述马铃薯浆液与果胶酶硫酸钠的重量比为1:(0.00015~0.00025);C. Add pectinase and sodium sulfite to the potato slurry obtained in step B, and react for 1-2 hours at a temperature of 45-55° C. and a pH value of 3-4. The weight of the potato slurry and pectinase The ratio is 1:(0.0001~0.0002), and the weight ratio of the potato slurry to pectinase sodium sulfate is 1:(0.00015~0.00025);
D、将经过步骤C处理得到的马铃薯浆液进行固液分离得到马铃薯汁与马铃薯颗粒沉淀;D. Solid-liquid separation is performed on the potato slurry obtained through step C to obtain potato juice and potato particle precipitation;
E、将马铃薯颗粒沉淀低温烘干或晒干后粉碎得到马铃薯生粉。E. Precipitating potato granules is dried at low temperature or sun-dried, and then pulverized to obtain potato starch.
该方法先将新鲜的马铃薯清洗、去皮处理后,加水捣碎成马铃薯浆液,然后添加果胶酶,接着马铃薯浆液进行固液分离得到马铃薯汁与马铃薯颗粒沉淀,由于事先利用果胶酶将马铃薯中含有的果胶降解,使得果胶中含有的水分被析出,这样经过固液分离后,马铃薯颗粒沉淀中的含水量就大大降低,可以大大减少马铃薯颗粒沉淀烘干所需要的时间,实现节能减排,而且该方法加工过程简单,加工成本较低,加工效果较好。In this method, fresh potatoes are first cleaned and peeled, then mashed with water to form a potato slurry, then pectinase is added, and then the potato slurry is subjected to solid-liquid separation to obtain potato juice and potato granules. The pectin contained in it is degraded, so that the water contained in the pectin is separated out, so that after solid-liquid separation, the water content in the potato particle precipitation is greatly reduced, which can greatly reduce the time required for potato particle precipitation and drying, and realize energy saving. emission reduction, and the method has simple processing process, low processing cost and good processing effect.
在步骤B中,将清洗去皮的马铃薯放入清水中是为了在捣碎马铃薯时能够使其碎粉的更加充分,清水的量不能太多,过多会给马铃薯的捣碎工序造成不必要的麻烦,过少又不能使马铃薯粉碎彻底,通常情况下,所述马铃薯与清水的重量比优选为1:0.3。In step B, the purpose of putting the cleaned and peeled potatoes into clear water is to make the powder more fully when mashing the potatoes. Trouble, too little can not make the potato crushed thoroughly, usually, the weight ratio of the potato and water is preferably 1:0.3.
为了提高果胶酶的降解效果,在步骤C中,所述果胶酶的反应温度为50℃、PH值为3.5,反应时间为2小时。进一步的是,在步骤C中,所述马铃薯浆液与果胶酶的重量比为1:0.00015。In order to improve the degradation effect of pectinase, in step C, the reaction temperature of the pectinase is 50° C., the pH value is 3.5, and the reaction time is 2 hours. Further, in step C, the weight ratio of the potato slurry to pectinase is 1:0.00015.
所述马铃薯生粉和马铃薯汁采用如下方法加工而成,具体方法如下所述:Described raw potato flour and potato juice are processed by the following method, and the specific method is as follows:
a、选取新鲜的马铃薯并将其进行清洗、去皮处理;a, select fresh potatoes and clean and peel them;
b、将清洗去皮的马铃薯进行压榨处理得到马铃薯汁和马铃薯榨干物;b. Pressing the cleaned and peeled potatoes to obtain potato juice and dried potatoes;
c、将步骤b得到的马铃薯榨干物低温烘干或晒干后粉碎得到马铃薯生粉。c. The dried potato product obtained in step b is dried at low temperature or dried in the sun, and then pulverized to obtain potato starch.
该方法利用新鲜的马铃薯进行压榨处理,不但可以将马铃薯榨干物低温烘干或晒干后粉碎得到马铃薯生粉还能够得到营养价值较高的马铃薯汁,该方法大大提高了马铃薯的利用率,同时加工方法简单,成本低。The method utilizes fresh potatoes for pressing, not only can dry the dried potatoes at low temperature or sun-dry them, and then pulverize them to obtain raw potato powder, but also obtain potato juice with high nutritional value. This method greatly improves the utilization rate of potatoes, and at the same time The processing method is simple and the cost is low.
另外,所述马铃薯生粉还可以是马铃薯淀粉,所述马铃薯淀粉采用如下方法制备:以新鲜的马铃薯为原料,经清洗、破碎、过滤、脱水、干燥得到马铃薯淀粉。In addition, the potato starch can also be potato starch, and the potato starch is prepared by the following method: fresh potatoes are used as raw materials, and the potato starch is obtained by washing, crushing, filtering, dehydrating and drying.
所述芦丁粉采用如下方法得到,具体方法如下所述:Described rutin powder adopts following method to obtain, and concrete method is as follows:
S1、选取完整的苦荞籽并清洗干净;S1, choose the complete tartary buckwheat seeds and clean them;
S2、将清洗干净的苦荞籽放入清水中,在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105-110℃的环境中进行烘干处理,烘干时间为20-200分钟;S2. Put the cleaned tartary buckwheat seeds into clean water, soak them for 2-24 hours at 10-50°C, drain the tartary buckwheat seeds after soaking, and then place the drained tartary buckwheat seeds Carry out drying treatment in an environment of -110°C, and the drying time is 20-200 minutes;
S3、将烘干后的苦荞籽放入盛装有碱性溶液的容器中,所述苦荞籽与碱性溶液的重量比为1:(5-20),所述碱性溶液的pH值为8~9,温度为90℃,然后将密封的容器放入超声波环境中进行超声波恒温浸提,所述超声波恒温浸提的时间为10-40min,所述超声波恒温浸提的温度为60-90℃,浸提结束后将密封的容器取出并冷却;S3. Put the dried tartary buckwheat seeds into a container filled with an alkaline solution, the weight ratio of the tartary buckwheat seeds to the alkaline solution is 1: (5-20), and the pH value of the alkaline solution is 8 to 9, the temperature is 90°C, and then the sealed container is placed in an ultrasonic environment for ultrasonic constant temperature leaching. The time of the ultrasonic constant temperature leaching is 10-40min, and the temperature of the ultrasonic constant temperature leaching is 60- 90°C, take out the sealed container after leaching and cool it down;
S4、对容器中的液体进行抽滤处理,得到苦荞浸提液与浸提过后的苦荞籽,并将浸提过后的苦荞籽进行干燥处理;S4, performing suction filtration on the liquid in the container to obtain tartary buckwheat extract and leached tartary buckwheat seeds, and drying the leached tartary buckwheat seeds;
S5、在步骤S4得到的苦荞浸提液中加入酸性溶液调节混合液体的pH值至3.5-4,然后静置得到芦丁沉淀物,并对芦丁沉淀物进行干燥得到芦丁粉。S5, adding an acidic solution to the tartary buckwheat extract obtained in step S4 to adjust the pH value of the mixed liquid to 3.5-4, then standing still to obtain rutin precipitate, and drying the rutin precipitate to obtain rutin powder.
该芦丁粉制备方法采用整粒的苦荞籽作为原料,将苦荞籽清洗干净后先放入清水中在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105-110℃的环境中进行烘干处理,接着将苦荞籽放入盛装有碱性溶液的容器中进行超声波恒温浸提使苦荞籽的种皮中含有的芦丁扩散,苦荞籽种皮中含有的芦丁同时向内、向外扩算,向外扩散至碱性溶液中,向内扩散至苦荞芯中,接着进行抽滤处理得到苦荞浸提液与浸提过后的苦荞籽,最后将苦荞浸提液静置得到芦丁沉淀物,并对芦丁沉淀物进行干燥得到芦丁粉,由于受种皮和苦荞壳的包裹,采用苦荞整粒碱液提取时可以避免苦荞芯中的淀粉进入到浸提液中造成淀粉糊化,同时,将苦荞籽清洗干净后先放入清水中在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105-110℃的环境中进行烘干处理,这样可以使苦荞芯外层或整个糊化,从而进一步避免苦荞芯中的淀粉进入到浸提液中造成淀粉糊化,这样只需将苦荞浸提液静置一端时间后便可以很容易的将苦荞芦丁分离出来,成本非常低,同时,该方法是从苦荞种皮中提取苦荞芦丁,而苦荞种皮中含有的芦丁含量是最高的,这样可以提取出更多的苦荞芦丁,提高了效率与产量。The preparation method of the rutin powder uses whole tartary buckwheat seeds as raw materials, cleans the tartary buckwheat seeds, puts them into clear water and soaks them for 2-24 hours at 10-50°C, and drains the tartary buckwheat seeds after soaking , and then dry the tartary buckwheat seeds in an environment with a temperature of 105-110°C, and then put the tartary buckwheat seeds into a container filled with an alkaline solution for ultrasonic constant temperature extraction to make the tartary buckwheat seeds The rutin contained in the seed coat diffuses, and the rutin contained in the seed coat of the tartary buckwheat seed expands inward and outward at the same time, diffuses outward into the alkaline solution, diffuses inward into the core of the buckwheat, and then undergoes suction filtration Treat tartary buckwheat extract and tartary buckwheat seeds after extraction, finally leave the tartary buckwheat extract to obtain rutin precipitate, and dry the rutin precipitate to obtain rutin powder. For the wrapping of the buckwheat shell, when the whole grain of tartary buckwheat is extracted with lye, it can prevent the starch in the tartary buckwheat core from entering the extract solution to cause starch gelatinization. Soak at 50°C for 2-24 hours, drain the tartary buckwheat seeds after soaking, and then dry the drained tartary buckwheat seeds at a temperature of 105-110°C, so that the tartary buckwheat core can be made The outer layer or the entire gelatinization, so as to further prevent the starch in the tartary buckwheat core from entering the extract solution to cause starch gelatinization, so that the tartary buckwheat extract can be easily extracted after standing for a while. The cost is very low, and at the same time, the method is to extract tartary buckwheat rutin from the tartary buckwheat seed coat, and the rutin content contained in the tartary buckwheat seed coat is the highest, so that more tartary buckwheat rutin can be extracted D, improved efficiency and output.
在上述实施方式中,为了使苦荞芯整个糊化形成一个整体,就必须使得整个苦荞芯被清水泡透,为了达到上述目的,在步骤S2中,将清洗干净的苦荞籽放入清水中,在37℃下浸泡24小时。进一步的,为了使苦荞芯整个被快速糊化,在步骤S2中,将沥干水分的苦荞籽在温度为105℃的环境中进行烘干处理。所述碱液可以是现有的各种碱性溶液,为了降低成本,在步骤S3中,所述碱性溶液优选为石灰水,由于石灰石获取容易,价格便宜,由此制成的石灰水成本非常低,可以进一步降低苦荞芦丁提取的成本。In the above embodiment, in order to gelatinize the whole tartary buckwheat core to form a whole, it is necessary to soak the whole tartary buckwheat core with clear water. In order to achieve the above purpose, in step S2, put the cleaned tartary buckwheat seeds into clear water medium, soak at 37°C for 24 hours. Further, in order to quickly gelatinize the whole tartary buckwheat core, in step S2, dry the tartary buckwheat seeds drained of water in an environment with a temperature of 105°C. The lye can be various existing alkaline solutions. In order to reduce costs, in step S3, the alkaline solution is preferably lime water. Because limestone is easy to obtain and cheap, the cost of lime water produced thus is Very low, can further reduce the cost of buckwheat rutin extraction.
选取完整的苦荞籽并清洗干净,然后将清洗干净的苦荞籽放入清水中,在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105℃的环境中进行烘干处理,烘干时间为20-200分钟,接着将烘干的苦荞籽分为16组,每组苦荞籽的重量为100g,向每组中分别加入不同重量的pH值为8~9石灰水,在80℃的条件下超声波恒温浸提不同时间后抽滤,测定芦丁浸提得率,所述芦丁浸提得率是指浸提液中的芦丁含量占苦荞籽总芦丁含量的百分比,各组的反应条件以及测定结果如下表3所示:Select whole tartary buckwheat seeds and clean them, then put the cleaned tartary buckwheat seeds into clean water, soak for 2-24 hours at 10-50°C, drain the tartary buckwheat seeds after soaking, and then drain The tartary buckwheat seeds with moisture are dried in an environment with a temperature of 105° C., and the drying time is 20-200 minutes. Then, the dried tartary buckwheat seeds are divided into 16 groups, and the weight of each group of tartary buckwheat seeds is 100 g. Add different weights of lime water with a pH value of 8 to 9 to each group, perform ultrasonic constant temperature leaching at 80°C for different periods of time, and then suction filter to determine the rutin extraction yield. Refers to the percentage of the rutin content in the extract to the total rutin content of tartary buckwheat seeds. The reaction conditions and measurement results of each group are shown in Table 3 below:
表3table 3
选取完整的苦荞籽并清洗干净,然后将清洗干净的苦荞籽放入清水中,在10-50℃下浸泡2-24小时浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105℃的环境中进行烘干处理,烘干时间为20-200分钟,接着将烘干的苦荞籽分为16组,每组苦荞籽的重量为100g,向每组中分别加入不同重量的pH值为8~9石灰水,在不同的温度条件下超声波恒温浸提20min后抽滤,测定芦丁浸提得率,所述芦丁浸提得率是指浸提液中的芦丁含量占苦荞籽总芦丁含量的百分比,各组的反应条件以及测定结果如下表4所示:Select whole tartary buckwheat seeds and clean them, then put the cleaned tartary buckwheat seeds into clean water and soak them at 10-50°C for 2-24 hours. After soaking, drain the tartary buckwheat seeds and drain the water The tartary buckwheat seeds are dried in an environment with a temperature of 105° C., and the drying time is 20-200 minutes. Then, the dried tartary buckwheat seeds are divided into 16 groups, and the weight of each group of tartary buckwheat seeds is 100 g. Add different weights of lime water with a pH value of 8 to 9 in each group, suction filter after 20 minutes of ultrasonic constant temperature leaching under different temperature conditions, and measure the extraction yield of rutin. The extraction yield of rutin refers to The rutin content in the extract accounts for the percentage of the total rutin content of tartary buckwheat seeds, and the reaction conditions and measurement results of each group are shown in Table 4 below:
表4Table 4
从表3可以看出,当浸提温度为80℃时,随着浸提碱性溶液添加量的增加,芦丁浸提得率不断增加,当碱性溶液为500-1000g时,芦丁浸提得率增加明显,超过1000g,芦丁浸提得率增加变缓;从表4可以看出,当超声波浸提时间为20分钟时,随着浸提碱液添加量的增加,芦丁浸提得率不断增加,500-1000g时,芦丁浸提得率增加明显,超过1000g,芦丁浸提得率增加变缓;因此,为了提高效率,节约成本,同时最大限度的提高苦荞芦丁的浸提效率,在步骤S3中,所述苦荞籽与碱性溶液的重量比优选为1:10。It can be seen from Table 3 that when the extraction temperature is 80°C, the extraction yield of rutin increases continuously with the increase of the amount of alkaline solution added. When the alkaline solution is 500-1000g, the extraction rate of rutin The extraction rate increased significantly, and more than 1000g, the rutin extraction rate increased slowly; as can be seen from Table 4, when the ultrasonic extraction time was 20 minutes, along with the increase of the extraction lye addition, the rutin extraction rate increased slowly; The extraction rate continues to increase. When it is 500-1000g, the rutin extraction rate increases significantly. If it exceeds 1000g, the rutin extraction rate increases slowly; therefore, in order to improve efficiency and save costs, while maximizing the Ding leaching efficiency, in step S3, the weight ratio of the buckwheat seeds and the alkaline solution is preferably 1:10.
选取完整的苦荞籽并清洗干净,然后将清洗干净的苦荞籽放入清水中,在10-50℃下浸泡2-24小时,浸泡结束后将苦荞籽沥干水分,然后将沥干水分的苦荞籽在温度为105℃的环境中进行烘干处理,烘干时间为20-200分钟,接着将烘干的苦荞籽分为16组,每组苦荞籽的重量为100g,向每组中分别加入1000g的pH值为8~9石灰水,在不同的浸提温度条件下进行不同时间的超声波恒温浸提后抽滤,测定芦丁浸提得率,所述芦丁浸提得率是指浸提液中的芦丁含量占苦荞籽总芦丁含量的百分比,各组的反应条件以及测定结果如下表5所示:Select whole tartary buckwheat seeds and clean them, then put the cleaned tartary buckwheat seeds into clean water, soak for 2-24 hours at 10-50°C, drain the tartary buckwheat seeds after soaking, and then drain The tartary buckwheat seeds with moisture are dried in an environment with a temperature of 105° C., and the drying time is 20-200 minutes. Then, the dried tartary buckwheat seeds are divided into 16 groups, and the weight of each group of tartary buckwheat seeds is 100 g. Add 1000g of lime water with a pH value of 8 to 9 to each group, carry out ultrasonic constant temperature leaching for different times under different leaching temperature conditions, and then suction filter to measure the leaching yield of rutin. The extraction rate refers to the percentage of the rutin content in the extract to the total rutin content of tartary buckwheat seeds. The reaction conditions and measurement results of each group are shown in Table 5 below:
表5table 5
从表5可以看出,当苦荞籽与碱性溶液的重量比为1:10时,随着浸提温度的升高,芦丁浸提得率不断增加,60-80℃时,芦丁浸提得率增加明显,超过80℃,无明显增加;随着超声波浸提时间的延长,芦丁浸提得率不断缓慢增加,因此,为了提高效率,节约成本,同时最大限度的提高苦荞芦丁的浸提效率,在步骤S3中,所述超声波恒温浸提的温度优选为80℃;同时,从表5中可以看出,当浸提时间超过20分钟后,芦丁浸提得率几乎无增加,因此,为了提高效率,节约成本与时间,同时最大限度的提高苦荞芦丁的浸提效率,在步骤S3中,所述超声波恒温浸提的时间优选为20min。It can be seen from Table 5 that when the weight ratio of tartary buckwheat seeds to alkaline solution is 1:10, the extraction rate of rutin increases continuously with the increase of extraction temperature. The extraction yield increased significantly, and there was no significant increase when it exceeded 80°C; with the extension of ultrasonic extraction time, the extraction yield of rutin continued to increase slowly. Therefore, in order to improve efficiency and save costs, and at the same time maximize the The leaching efficiency of rutin, in step S3, the temperature of described ultrasonic constant temperature leaching is preferably 80 ℃; Simultaneously, as can be seen from Table 5, when leaching time exceeds 20 minutes, rutin leaching yield There is almost no increase. Therefore, in order to improve efficiency, save cost and time, and maximize the extraction efficiency of buckwheat rutin, in step S3, the ultrasonic constant temperature extraction time is preferably 20min.
另外,为了提高超声波恒温浸提的效率,所述超声波的频率为优选为100Hz。In addition, in order to improve the efficiency of ultrasonic constant temperature leaching, the frequency of the ultrasonic wave is preferably 100 Hz.
成型米生产中常用的添加剂有氯化钙、明矾、碱类及干酵素等。Commonly used additives in the production of shaped rice include calcium chloride, alum, alkalis and dry enzymes.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610431766.4A CN106072182A (en) | 2016-06-16 | 2016-06-16 | A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610431766.4A CN106072182A (en) | 2016-06-16 | 2016-06-16 | A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106072182A true CN106072182A (en) | 2016-11-09 |
Family
ID=57235846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610431766.4A Pending CN106072182A (en) | 2016-06-16 | 2016-06-16 | A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106072182A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111513272A (en) * | 2020-05-29 | 2020-08-11 | 湖南省农产品加工研究所 | Zero-additive compound nutritional fruit and vegetable buccal tablet and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520756A (en) * | 2003-04-11 | 2004-08-18 | �����п�����ʳƷ���̼�������˾ | Duck wheat comprehensive utilization process and its products produced thereby |
CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
CN102239984A (en) * | 2011-05-23 | 2011-11-16 | 厦门思露生物科技有限公司 | Bird nest health-care product buccal tablet |
CN105105110A (en) * | 2015-08-04 | 2015-12-02 | 江苏大学 | Making method of monascus and tartary buckwheat functional food and application thereof |
CN105394546A (en) * | 2015-12-23 | 2016-03-16 | 四川彝家山寨黑苦荞食品有限公司 | Black tartary buckwheat essence buccal tablet and processing method thereof |
-
2016
- 2016-06-16 CN CN201610431766.4A patent/CN106072182A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520756A (en) * | 2003-04-11 | 2004-08-18 | �����п�����ʳƷ���̼�������˾ | Duck wheat comprehensive utilization process and its products produced thereby |
CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
CN102239984A (en) * | 2011-05-23 | 2011-11-16 | 厦门思露生物科技有限公司 | Bird nest health-care product buccal tablet |
CN105105110A (en) * | 2015-08-04 | 2015-12-02 | 江苏大学 | Making method of monascus and tartary buckwheat functional food and application thereof |
CN105394546A (en) * | 2015-12-23 | 2016-03-16 | 四川彝家山寨黑苦荞食品有限公司 | Black tartary buckwheat essence buccal tablet and processing method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111513272A (en) * | 2020-05-29 | 2020-08-11 | 湖南省农产品加工研究所 | Zero-additive compound nutritional fruit and vegetable buccal tablet and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813113B (en) | Composition capable of regulating human flora and immune function | |
CN107259571A (en) | One kind is for canteen thing and preparation method thereof | |
CN104824512A (en) | Fruit-coarse cereal electuary and preparation method thereof | |
CN102726565A (en) | Tartary buckwheat-chrysanthemum health-preserving tea and preparation method thereof | |
CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
CN107509918A (en) | The processing technology of potato ground rice | |
CN105996028A (en) | Ginger extract, ginger fiber and preparation method of ginger extract and ginger fiber | |
CN107223846A (en) | A kind of suitable middle-aged and old grain healthcare powder | |
CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
CN106071681A (en) | A kind of processing method of Radix Et Rhizoma Fagopyri Tatarici powder | |
CN106560047A (en) | Preparation process for extrusion-molded Tartary buckwheat tea | |
CN107509938A (en) | The processing method of buckwheat potato noodles | |
CN107509954A (en) | The processing method of buckwheat potato quality control of fried instant food | |
CN102599512B (en) | Sea buckthorn nutrition powder and preparation method thereof | |
CN106072182A (en) | A kind of preparation method of Radix Et Rhizoma Fagopyri Tatarici potato fruit dried object mixing buccal tablet | |
CN105433390B (en) | A kind of fiddlehead Rosa roxburghii Tratt Siraitia grosvenorii composite particle beverage | |
CN107509955A (en) | A kind of preparation method of potato bitter buckwheat shaping rice | |
CN107637736A (en) | A kind of kanjak mannan sports drink and preparation method thereof | |
CN107509942A (en) | Buckwheat potato pasta and the processing method for being molded rice | |
CN106107469A (en) | Radix Et Rhizoma Fagopyri Tatarici buccal tablet preparation method based on dehydrated potato powder | |
CN107432304A (en) | The processing method of buckwheat potato cake | |
CN106071683A (en) | The processing method of Fagopyrum tataricum (L.) Gaertn. | |
CN111480835A (en) | Coconut chestnut and pearl vine stuffing and preparation method thereof | |
CN106070874A (en) | The preparation technology of Radix Et Rhizoma Fagopyri Tatarici tea | |
CN107509837A (en) | A kind of preparation method of potato bitter buckwheat shaped tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
RJ01 | Rejection of invention patent application after publication |